Sarissa Capital Management LP Long-Term Concentrated

Location: Greenwich, CT

CIK: 0001577524 · Show all filings

Period: Q1 2014 (← Previous) (Next →)

Filing Date: May 15, 2014

Total Value: $290M (100.0% shares, 0.0% debt)

Holdings (15)

— ARIAD PHARMACEUTICALS INC 33.3%

Value $96.72M Shares 12,000,000 Est. Cost $6.82 Unrealized —

DGX QUEST DIAGNOSTICS INC 15.5%

Value $44.89M Shares 775,000 Est. Cost $46.05 Unrealized -8.3%

— BIO-REFERENCE LABS INC 12.2%

Value $35.46M Shares 1,280,984 Est. Cost $27.20 Unrealized —

— IDENIX PHARMACEUTICALS INC 10.5%

Value $30.45M Shares 5,050,100 Est. Cost $5.98 Unrealized —

MRK MERCK & CO INC NEW 7.8%

Value $22.71M Shares 400,000 Est. Cost $31.29 Unrealized +14.3%

— MALLINCKRODT PUB LTD CO 6.0%

Value $17.43M Shares 274,895 Est. Cost $52.26 Unrealized —

— VIVUS INC 5.3%

Value $15.29M Shares 2,573,943 Est. Cost $9.08 Unrealized —

— REPROS THERAPEUTICS INC 3.4%

Value $9.945M Shares 560,600 Est. Cost $18.20 Unrealized —

— AVEO PHARMACEUTICALS 1.3%

Value $3.843M Shares 2,570,759 Est. Cost $1.84 Unrealized —

— LABORATORY CORP AMER HLDGS 1.3%

Value $3.715M Shares 37,824 Est. Cost $98.22 Unrealized —

— INTRA CELLULAR THERAPIES INC 0.8%

Value $2.303M Shares 126,695 Est. Cost $18.18 Unrealized —

— ONCONOVA THERAPEUTICS INC 0.8%

Value $2.219M Shares 350,000 Est. Cost $6.34 Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 0.7%

Value $2M Shares 50,000 Est. Cost $36.32 Unrealized 0.0%

— KINDRED BIOSCIENCES INC 0.6%

Value $1.887M Shares 101,825 Est. Cost $18.53 Unrealized —

— TARGACEPT INC 0.5%

Value $1.565M Shares 329,516 Est. Cost $4.75 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	ARIAD PHARMACEUTICALS INC	12,000,000	$96.72M	33.3%	$6.82	—	COM	04033A100
DGX	QUEST DIAGNOSTICS INC	775,000	$44.89M	15.5%	$46.05	-8.3%	COM	74834L100
—	BIO-REFERENCE LABS INC	1,280,984	$35.46M	12.2%	$27.20	—	COM $.01 NEW	09057G602
—	IDENIX PHARMACEUTICALS INC	5,050,100	$30.45M	10.5%	$5.98	—	COM	45166R204
MRK	MERCK & CO INC NEW	400,000	$22.71M	7.8%	$31.29	+14.3%	COM	58933Y105
—	MALLINCKRODT PUB LTD CO	274,895	$17.43M	6.0%	$52.26	—	SHS	G5785G107
—	VIVUS INC	2,573,943	$15.29M	5.3%	$9.08	—	COM	928551100
—	REPROS THERAPEUTICS INC	560,600	$9.945M	3.4%	$18.20	—	COM NEW	76028H209
—	AVEO PHARMACEUTICALS	2,570,759	$3.843M	1.3%	$1.84	—	COM	053588109
—	LABORATORY CORP AMER HLDGS	37,824	$3.715M	1.3%	$98.22	—	COM NEW	50540R409
—	INTRA CELLULAR THERAPIES INC	126,695	$2.303M	0.8%	$18.18	—	COM	46116X101
—	ONCONOVA THERAPEUTICS INC	350,000	$2.219M	0.8%	$6.34	—	COM	68232V108
ENTA	ENANTA PHARMACEUTICALS INC	50,000	$2M	0.7%	$36.32	0.0%	COM	29251M106
—	KINDRED BIOSCIENCES INC	101,825	$1.887M	0.6%	$18.53	—	COM	494577109
—	TARGACEPT INC	329,516	$1.565M	0.5%	$4.75	—	COM	87611R306